97 Search Results

q=Speaking%20engagements

Search Again


Lucas Sullivan , PhD

Email: lucas@fredhutch.org

Phone: (206) 667-7826

Dr. Lucas Sullivan studies cell metabolism under normal and cancerous conditions. He also aims to deepen the understanding of metabolism in general, working to discover new molecular products of metabolism and their roles in sustaining cell survival and growth. The current goals of the lab seek to span from translationally relevant projects, testing metabolism modifying therapies in preclinical cancer models, to basic science discovery, investigating new roles for coenzyme networks and identifying new metabolites, to better understand cell metabolism in cancer and beyond.

View Bio

Billie Swalla , PhD

Email: bjswalla@u.washington.edu

Phone: (206) 616-9367

Dr. Swalla's goal is to understand the evolution of the chordate body plan, a complex problem that requires interdisciplinary research. As vertebrates, humans are chordates, but there are also several groups of invertebrate chordates that her team study for clues to our evolution. The lab combine methods and approaches in phylogenetics, development, ecology and evolution to study the evolution of the chordate body plan from a deuterostome ancestor.

View Bio

Stephen Tapscott , MD, PhD

Email: stapscot@fredhutch.org

Phone: (206) 667-4499

Dr. Tapscott's research focuses on the regulation of gene expression during the development of muscle and the nervous system and how this relates to cancers and degenerative diseases of brain and muscle. He has translational research programs in cell and gene therapy for muscular dystrophies and clinical studies to identify the mechanisms of facioscapulohumeral muscular dystrophy.

View Bio

Timothy Thornton , PhD

Email: tathornt@u.washington.edu

Phone: (206) 543-8004

Dr. Thornton's research interest is in the area of statistical genetics, with an emphasis on statistical methodology for case-control genome-wide association studies (GWAS) in samples with related individuals and/or hidden population structure.

View Bio

Toshio Tsukiyama , PhD, DVM

Email: ttsukiya@fredhutch.org

Phone: (206) 667-4996

Dr. Tsukiyama is interested in understanding how chromatin structure is regulated in vivo.

View Bio

Sherilyn Tuazon , MD, MS

Email: stuazon@fredhutch.org

Phone: (206) 667-5479

Dr. Sherilyn Tuazon is developing better treatments for people with multiple myeloma. Her primary research goal is to create novel cellular therapies that provide lasting remissions and cures for multiple myeloma patients, with a focus on blood stem cell transplantation and immunotherapies, such as genetically modified T-cell therapies and radioimmunotherapy.

View Bio

Chaitra Ujjani , MD

Email: ujjani@uw.edu

Phone: (206) 606-1955

Dr. Ujjani has designed and led multi-center clinical trials that test new drug combinations for treating lymphomas and chronic lymphocytic leukemia (CLL), with the goals of more precisely targeting cancer while decreasing the intensity of side effects. She is also interested in immunotherapy and novel therapeutics for B-cell lymphoma and CLL.

View Bio

Joseph Unger , PhD, MS

Email: junger@fredhutch.org

Phone: (206) 667-2860

Dr. Unger specializes and is interested in the design and analysis for quality of life; cancer prevention; symptom control; and comparative effectiveness studies.

View Bio

Takuma Uo , Ph.D.

Email: tuo@uw.edu

Phone: 206-897-5463

Age is the most common risk factor for prostate cancer, with the rapid rise in its incidence after age 50. As a member of the prostate cancer research group in Division of Gerontology and Geriatric Medicine, Dr. Uo is focused on understanding molecular logics behind adaptive resistance of prostate cancer cells to the most forefront androgen-targeted therapies. Specifically, his research program examines the cell autonomous and nonautonomous mechanisms that enable prostate cancer progression, including the constitutively-active isoforms of androgen receptor, the metabolic rewiring, and the extracellular fuel supply from tumor microenvironment and adipose tissues. He harnesses in-depth knowledge and advanced technologies of molecular, cellular, chemical, synthetic, and computational biology to help develop next-generation of therapeutics to improve patient survival.

View Bio

Michael Wagner , MD

Email: wagnermj@uw.edu

The focus of Dr. Wagner's work is to understand the molecular drivers of sarcomas and to translate this knowledge to develop clinical trials, ultimately leading to new treatments for sarcoma.

View Bio

Edus (Hootie) Warren , MD, PhD

Email: ehwarren@fredhutch.org

Phone: (206) 667-6441

Dr. Warren's research focuses on the dissection of human antitumor immune responses at the cellular and molecular level. Dr. Warren is also medical oncologist specializing in leukemia and bone marrow transplant.

View Bio

Paul Wiggins , PhD

Email: pwiggins@uw.edu

Phone: (626) 437-3761

Dr. Wiggins's research group focuses on achieving a greater understanding of how biological systems function and are structured at the microscopic scale. In particular, he is focused on Bacterial cell biology, chromosome structure and bacterial ultra-structure; quantitative Imaging; and DNA/membrane statistical mechanics.

View Bio

Ellen Wijsman , PhD

Email: wijsman@u.washington.edu

Phone: (206) 543-8987

Dr. Wijsman's research is directed towards the development and application of quantitative methods for analysis of human genetic data, including statistical techniques of gene mapping, modeling modes of inheritance, and identifying regions of identify-by-descent through linkage disequilibrium analysis.

View Bio

Fei Xia , PhD, MS

Email: fxia@u.washington.edu

Phone: (206) 543-9764

Dr. Xia's research area is computational linguistics. Her research covers a wide range of NLP tasks including morphological analysis, part-of-speech tagging, grammar extraction and grammar generation, treebank development, machine translation, named-entity recognition, and information extraction.

View Bio

Ka Yee Yeung , PhD

Email: kayee@uw.edu

Phone: (253) 692-4924

Dr. Yeung has extensive experience in the design of algorithms for the mining and integration of big data. She also has research expertise/interest spanning multiple disciplines, including computer science, statistics, computational biology, cancer biology and systems biology.

View Bio

Cathy Yeung , PhD, PharmD

Email: cathyy@u.washington.edu

Phone: (206) 897-4709

Dr. Yeung's research includes both basic science and translational studies, and spans from the determination of molecular mechanisms of altered drug metabolism using 3-dimensional cell culture techniques to the evaluation of the effect of drugs and nutritional supplements on health outcomes in patients receiving hemodialysis. She is also involved in the development of a kidney on a chip microphysiological system that can be used in preclinical drug toxicity screening.

View Bio

Lue-Ping Zhao , PhD

Email: lzhao@fredhutch.org

Phone: (206) 667-6927

Being trained in biostatistics/bioinformatics, epidemiology and genetics, Dr. Zhao's current interest in STTR includes how to use omics methodology to dissect solid tumor etiology and mechanism with either expression arrays, SNP arrays, or short-read sequencing methods. Further, he is interested in utilizing large and complex electronic medical records with modern genomic technologies for translational bioinformatics studies.

View Bio